08:00 , Jan 16, 2006 |  BC Week In Review  |  Clinical News

CellCorrect KvA-40 LAb Kit regulatory update

CeMines International, a subsidiary of CeMines Inc., received CE Mark approval in the EU for CellCorrect LAb, a lung cancer antibody detection kit using Molecular FingerPrinting technology, to aid in the detection and...
07:00 , May 23, 2005 |  BC Week In Review  |  Clinical News

CellCorrect LAb regulatory update

CeMines submitted a 510(k) clearance application for CellCorrect LAb detection kit for lung cancer. The antibody test kit detects cancer cells using the CeMines' Molecular FingerPrinting technology. CeMines Inc., Golden, Colo.   Product: CellCorrect LAb...